Fig. 1From: Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective studyProportion of patients achieving ≥50% reduction from baseline in monthly headache days after 2 treatment cycles. PBS, Pharmacy Benefits SchemeBack to article page